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Aim: Huntingtin protein (Htt) was a neuropathological hallmark in human Huntington’s Disease. The study aimed to investigate whether 
the macroautophagy regulator, Beclin1, was involved in the degradation of Htt.  
Methods: PC12 cells and primary cultured brain neurons of rats were examined. pDC316 adenovirus shuttle plasmid was used to 
mediate the expression of wild-type Htt-18Q-552 or mutant Htt-100Q-552 in PC12 cells. The expression of the autophagy-related pro-
teins LC3 II and Beclin1, as well as the lysosome-associated enzymes Cathepsin B and L was evaluated using Western blotting. The 
locations of Beclin1 and Htt were observed with immunofluorescence and confocal microscope.
Results: Htt552 expression increased the expression of LC3 II, Beclin1, cathepsin B and L in autophagy/lysosomal degradation path-
way.  Treatment with the autophagy inhibitor 3-MA or the proteasome inhibitors lactacystin and MG-132 increased Htt552 levels in 
PC12 cells infected with Ad-Htt-18Q-552 or Ad-Htt-100Q-552.  The proteasome inhibitor caused a higher accumulation of Htt552-18Q 
than Htt552-100Q, and the autophagy inhibitor resulted in a higher accumulation of Htt552-100Q than Htt552-18Q.  Similar results 
were observed in primary cultured neurons infected with adenovirus. In Htt552-expressing cells, Beclin1 was redistributed from the 
nucleus to the cytoplasm. Htt siRNA prevented Beclin1 redistribution in starvation conditions. Blockade of Beclin1 nuclear export by 
leptomycin B or Beclin1 deficiency caused by RNA interference induced the formation of mHtt552 aggregates.
Conclusion: Beclin1 regulates the accumulation of Htt via macroautophagy.
Keywords: Huntingtin (Htt); Beclin1; protein degradation; autophagy; RNA interference; ubiquitin-proteasome system; autophagy/lyso-
some pathway
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Introduction
Huntington’s disease (HD) is a neurodegenerative disorder 
caused by the expansion of a trinucleotide (CAG) repeat 
encoding polyglutamine (polyQ) in the N-terminal region of 
the Huntingtin (Htt) protein.  A neuropathological hallmark 
in human HD and mouse models is the intracellular accumu-
lation of N-terminal Htt fragments
[1], suggesting that aber-
rant Htt proteolysis and/or dysfunctional clearance of Htt 
fragments may underlie the neuropathology in HD.  Several 
proteases, including caspases, calpains and aspartyl endopep-
tidases, cleave Htt within the N-terminal region, and in vitro 
studies have demonstrated that N-terminal Htt fragments 
with expanded polyglutamine have enhanced cytotoxicity
[2].   
Although some evidence shows that wild-type Htt has an 
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essential role in developmental and cellular processes
[3–7], 
the physiological role of Htt still needs further investigation.   
DiFiglia’s lab was the first to find that cytoplasmic mHtt aggre-
gates had a distribution similar to that of autophagosomes-lys-
osomes in postmortem HD brains
[8] and suggested a possible 
role for autophagy in HD.  Later, with in vitro and invertebrate 
model systems, other work also indicated that autophagy is 
an important component of the cellular response to mHtt
[9–13].   
Recently, Heng et al employed a novel knock-in HD mouse 
model and reported an association of mHtt immunoreactive 
cytoplasmic aggregates with autophagosomes and the early 
and sustained induction of autophagy-associated proteins, 
suggesting that autophagy is indeed an important component 
of the neuronal response to mHtt expression in vivo
[14].
Htt is the first
 neuronal protein shown to be a caspase 
substrate with defined sites
 for caspase-3 at amino acids 513 
and 552, for caspase-2 at amino
 acid 552, and for caspase-6 at 
amino acid 586.  Using an antibody that only detects caspase-744
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 et al demonstrated
 that Htt was 
cleaved in vivo specifically at the caspase consensus
 site at 
amino acid 552.  This form of Htt was also detected in control 
human brains and in HD brains with early phase neuropathol-
ogy, as well as in wild-type and HD transgenic mouse brains 
before the onset of neurodegeneration.  These data suggest 
that caspase cleavage of Htt would be a normal
 physiological 
event
[15].  However, in HD, the N-terminal fragments resulting 
from the cleavage of mutant Htt have the potential to increase 
cytotoxicity and accumulation because of the presence of the 
expanded polyglutamine tract.  In previous research, various 
fragments (N-terminal 171 aa or 5’-3 kb) were used
[13, 16], but 
all of these fragments do not exist in physiological conditions.   
In this study, the 552 aa fragment was used to produce results 
which would approach the HD pathophysiological conditions 
closely.
In HD, mHtt forms aggregates (Htt body) both in the 
nucleus and the cytoplasm, including in the neuronal 
synapse
[17, 18].  Numerous studies verified that an expanded 
polyQ tract provoked a dominant gain-of-function neurotox-
icity.  Treatment with Congo Red or trehalose reduced the 
accumulation of overexpressed expanded polyQ-positive 
proteins, increased the rate of their degradation and alle-
viated neurological symptoms in HD transgenic mouse 
models
[12, 19, 20].  Eukaryotic cells have two major protein degra-
dation pathways.  One is the ubiquitin-proteasome pathway 
that is responsible for the selective degradation of most short-
lived proteins
[21, 22].  Neuronal N-terminal-Htt inclusions are 
highly ubiquitinated.  However, it was reported that mutant 
Htt impaired synaptic ubiquitin-proteasome system activity in 
cultured neurons and in HD mouse brains expressing either 
N-terminal or full-length mutant Htt
[17].  The other protein deg-
radation pathway is the autophagy/lysosomal pathway that 
consists of the delivery of intracellular and endocytosed pro-
teins to the lysosomes.  Autophagosomes sequester the cyto-
plasmic portions, intracellular organelles fuse with lysosomes 
and the sequestered materials are then degraded by cathepsins 
found in the lysosomes
[23, 24].  The addition of 3-methyladenine 
(3-MA), an inhibitor of class III phosphatidylinositol 3-kinase 
and autophagy, increased Htt aggregate formation in x57 cells, 
while rapamycin, an inducer of autophagy, reduced them
[11].   
The transgenic mice with N-terminal fragment had improved 
performance in behavioral tests when the Htt aggregates 
were decreased.  These results support a potential role of both 
the proteasome and autophagy in regulating the turnover of 
expanded polyQ proteins.
Class III PI 3-kinase and its product, phosphatidylinositol 
3-phosphate (PI 3-P), are involved in the autophagy signaling 
pathway.  The PI 3-kinase inhibitors, wortmannin and 3-MA, 
can inhibit the formation of autophagosomes.  This indicates 
that PI 3-kinase activity is important in the early phase of 
autophagic vesicle formation
[25].  Beclin1 is the ortholog of 
Atg6, a part of the PI 3-kinase complex, and it plays a role in 
autophagic vesicle formation in yeast.  The PI3-kinase com-
plex may also be functional in the mammalian system
[26].  The 
expression of Beclin1 in MCF7 cells activated the formation 
of autophagic vesicles and the degradation of long-lived pro-
teins upon amino-acid starvation.  In addition, 3-MA is able to 
restrain autophagy induced by Beclin1 in MCF-7 cells
[27].  The 
accumulated mutant Htt can recruit Beclin1 and impair the 
Beclin1-mediated long-lived protein turnover.  Thus, seques-
tration of Beclin1 in the vulnerable neuronal population of HD 
patients might reduce Beclin1 function and the autophagic 
degradation of mutant Htt in these neurons
[28].
In this study, we verified that the autophagy/lysosome 
pathway is involved in the degradation of both wild-type and 
mutant Htt552 in PC12 cells and primary neurons.  Htt stimu-
lates the nuclear export of Beclin1, thereby facilitating the 
autophagic process.  Additionally, we found that Beclin1 was 
an important protein involved in Htt552 degradation, particu-
larly degradation of the mutant form of the protein.  
Materials and methods
Materials and drugs
The Htt expression plasmids, pcDNA3-Htt-18Q-969aa-552stop 
and pcDNA3-Htt-100Q-969aa-552stop, were provided by Dr   
Marian DiFIGLIA (Massachusetts General Hospital and Har-
vard Medical School, USA).  Both of the two constructs encode 
an N-terminal Htt fragment of 969 aa with a stop codon after 
552 aa.  The 18Q is a wild-type Htt with 18 repeats of CAG, 
while 100Q is a mutant Htt with 100 CAG repeats.  Rat PC12 
cells were purchased from the Shanghai Institute of Cell Biol-
ogy (Shanghai, China).  Leptomycin B was purchased from 
Merck Chemicals (Germany).  The 3-methyladenine (3-MA) 
was obtained from Sigma-Aldrich Co (St Louis, MO, USA).   
The MG-132 and lactacystin were from Enzo Life Sciences, 
Inc (Farmingdale, NY, USA).  Concentrations of 10 nmol/L 
leptomycin B, 10 mmol/L 3-MA, 10 nmol/L MG-132, and 200 
nmol/L lactacystin were used in experiments.
 
Cell culture
The PC12 cells were cultured in 60-mm dishes in DMEM 
supplemented with 10% FBS, 4.5% glucose, 100 mg/L strepto-
mycin, 100 units/L penicillin, and incubated in a humidified 
atmosphere of 5% CO2 at 37 °C.  
Pregnant rats at embryonic day 16 were used to create pri-
mary neuronal cultures.  This procedure included the anesthe-
tization of the rat, sterilization of the incision site and removal 
of the embryos into a dish containing pre-cooled sterile PBS.   
The brains of the pups were collected, and then the cortical 
hemispheres were dissected and placed in a new tube with 10 
mL PBS on ice.  The tissue was rinsed with pre-cooled PBS 2–3 
times, incubated with 10 mL of 2.5% trypsin: DMEM medium 
(1:1) at 37 °C for 15–20 min, centrifuged at 1200 r/min at 4 °C 
for 3 min and rinsed 2–3 times with DMEM/F12 medium 
containing 10% FBS.  The tissue pellets were resuspended 
and incubated in 0.125 mg DNase I in 10 mL of DMEM/F12 
containing 10% FBS at 37 °C for 5 min.  Samples were then 
centrifuged at 1400 r/min at 4°C for 3 min.  Cells were resus-
pended to the desired concentration with neurobasal medium 
(NBM) supplemented with B27, 1% pen/strep and 25 μmol/L 
glutamine.  Single cell suspensions were obtained by pass-745
www.chinaphar.com
Wu JC et al
Acta Pharmacologica Sinica
npg
ing the cell suspension through a 40-μm cell strainer.  Cells 
were plated on poly-D-lysine-coated dishes or plates with a 
density of 1×10
5 cells/cm
2 and then incubated in a humidi-
fied atmosphere of 5% CO2 at 37 °C.  After 3–4 d, half of the 
medium was replaced with fresh DMEM with 10% FBS/Pen-
strep and 10 μmol/L AraC.  After another 24 h, the medium 
was replaced with NBM supplemented with B27, pen/strep, 
and 2 mmol/L L-glutamine.  Lastly, half of the medium was 
replaced every 3–4 d.  The neurons matured after 7
 d in cul-
ture.
Adenovirus mediated Htt expression system
The N-terminus of wild-type (18Q) and mutant (100Q) Htt, 
with 3 kb cDNAs and a stop codon at 552 aa, were cloned 
into the pDC316 adenovirus shuttle plasmid.  Wild-type and 
mutant Htt cDNAs were excised from their parental vec-
tors using BamHI and XbaI and then ligated to BamHI/XbaI-
digested pUC18, an intermediate vector.  Next, these cDNAs 
were ligated to BglII/SalI-digested pDC316.  Two independent 
adenovirus shuttle plasmids, pDC316-Htt-18Q-552stop and 
pDC316-Htt-100Q-552stop, were obtained.
Three independent adenoviruses, including Ad-null, Ad-
Htt-18Q-552stop, and Ad-Htt-100Q-552stop, were obtained 
by co-transfection of 293 cells with the backbone plasmid 
pBHG10 and the shuttle plasmids, pDC316, pDC316-Htt-18-
Q-552stop, or pDC316-Htt-100Q-552stop.  Cytopathic effects 
happened at 7th day after transfection and both the cells and 
the supernatant were collected at 10th day. This was the first 
generation adenovirus.  The later proliferation of adenovirus 
was also manuplated in 293 cells.  The fourth generation aden-
ovirus was used in the later experiments.  
Protein preparation and Western blot analysis 
Cells were harvested and rinsed with ice-cold PBS twice.  Each 
volume of the cell pellet was lysed by five volumes of the 
Western blot lysing buffer.  After being centrifuged at 10 600×g 
at 4 °C for 10 min, the supernatant was preserved at -70 °C for 
later use.  The protein concentration was determined with a 
BCA kit (Pierce, USA).  The protein samples were denatured 
by boiling for 5 min in loading buffer, subjected to 10% SDS-
PAGE, and then electroblotted onto nitrocellulose membranes 
(Amersham Biosciences, Piscataway, USA).  The membranes 
were then blocked with 5% non-fat milk for 1 h and first 
probed with the mouse monoclonal Htt antibody (Chemicon, 
Temecula, CA) at a dilution of 1:2000 overnight at 4 °C.  Next, 
the membranes were incubated with a horseradish peroxidase-
conjugated secondary antibody for 1 h.  Lastly, they were visu-
alized by an enhanced chemiluminescence (ECL) kit (Pierce, 
Rockford, IL, USA).
Immunofluorescence
PC12 cells were plated in 24-well plates containing poly-D-
lysine-coated coverslips, and the transfection was performed 
when cells reached 80% confluence, approximately 24 h after 
plating.  According to the MOI 20, mixed adenovirus in 0.25 
mL medium with 5% FBS was transferred to planted cells.   
After a 2-h incubation, the medium was removed and the cells 
were cultured in 0.5 mL of fresh, antibiotic-free DMEM.  Every 
24 h, the medium was changed with fresh, antibiotic-free com-
plete medium.  After 24, 48, or 72 h, cells were washed with 
PBS and fixed in pre-cooled ethanol for 15 min at room tem-
perature.  After another wash with PBS, they were incubated 
in PBS with 0.1% Triton X-100 for 10 min.  The cells were then 
incubated for 1 h in a blocking solution of PBS supplemented 
with 2% non-fat milk (Guangming Milk, Shanghai, China) at 
room temperature.  Next, the cells were incubated overnight 
at 4 °C in a blocking solution containing the primary antibody.   
The cells were then incubated for 2 h at room temperature 
with secondary antibodies coupled with fluorophores.  The 
expression of Htt was detected with the mouse monoclonal 
Htt antibody at a dilution of 1:2000 as the first antibody and 
the FITC-conjugated donkey anti-mouse antibody with a dilu-
tion of 1:800 as the second antibody.  The expression of Beclin1 
was detected with the rabbit polyclonal BECN antibody (Santa 
Cruz Biotechnologies, Santa Cruz, CA, USA) with a dilution of 
1:400 as the first antibody and cy3-conjugated donkey anti-rab-
bit antibody with a dilution of 1:800 as the second antibody.   
Lastly, cells were incubated with 300 nmol/L 4’,6-diamidino-
2-phenylindole (DAPI) for 15 min.  The immunostained cells 
were examined with laser confocal microscopy (C1Sl, Nikon, 
Tokyo, Japan).  
Quantitative analysis of cells 
To quantify the location of Htt and Beclin1, PC12 cells were 
examined with a 60×objective.  Confocal images were obtained 
from ten fields each for the control and treatment conditions.   
Each field contained 15–20 cells for analysis.  Images were 
coded before evaluation.  Up to 100 cells per coverslip were 
selected at random for the analysis of the signal intensity 
using Sigma Scan Pro 5.  The boundaries of the cell membrane 
and the nucleus were outlined, and the average intensity was 
recorded.  The immunoreactivity of Htt and Beclin1 was deter-
mined with Sigma Scan Pro 5 using a calculation of the ratio 
of the stain intensity in the nucleus and in the whole cell.  At 
least 50 cells were used for the quantitative analysis.  All data 
are presented as the mean±SEM.  Statistical analysis was car-
ried out using Dunnett’s test, considering P<0.05 as significant.   
RNA interference
The double-stranded Beclin1 and Htt siRNA sequences were 
designed according to the cDNAs sequences of rat Beclin1 
and human Htt.  We chose the most effective pair among 
three pairs tested for their efficiency in the knockdown of tar-
get genes.  The sequences used for the experiments included 
5’-UGAGGAUGACAGUGAACAGTT-3’ and 5’-CUGUU-
CACUGUCAUCCUCATT-3’ for Beclin1 and 5’-GCUUCG-
GAGUGACAAGGAATT-3’ and 5’-UUCCUUGUCACUC-
CGAAGCTG-3’ for Htt.  The siRNA was synthesized by the 
Genepharma company in China.  
PC12 cells were plated in 24-well plates and incubated in 
complete medium without antibiotics for 24 h.  The knock-
down experiment was then performed.  First, 1 μL Lipo-746
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fectamine 2000 was diluted with 50 μL Opti-MEMI reduced 
serum medium and then incubated at room temperature for 
5 min.  A volume of 2 μL siRNA was also diluted with 50 μL 
Opti-MEMI reduced serum medium.  The two solutions were 
gently mixed and incubated for another 20 min at room tem-
perature.  The mixture solution was added to cells containing 
approximately 400 μL normal medium.  The cells were then 
incubated in a humidified atmosphere of 5% CO2 at 37 °C.   
After the cells were transfected for 24 h, the efficiency of the 
siRNAs was determined by Western blot.
Results
The high efficiency expression of Htt552 in PC12 cells 
The expression of Htt552 was achieved by insertion of a stop 
codon after amino acid residue 552 in the 3-kb Htt cDNA.  As 
expected, the expressed wild-type Htt with 1–552 aa (Htt552-
18Q) migrated at 89 kDa, while mutant Htt (Htt552-100Q) 
migrated at 115 kDa (Figure 1A).  Our immunofluorescent 
results showed that the transfection efficiency was approxi-
mately 60%–70% at an MOI 30 (Figure 1B) and approximately 
90% at an MOI 100 (data not shown).  Both wild-type and 
mutant Htt552 were primarily distributed in the cytoplasm 
with little or no aggregation.
Htt552 expression increased autophagy activity
LC3 II is an important protein involved in the formation of 
autophagosomes.  Western blot analysis showed that the level 
of LC3 II was lower in both normal cells and adenovirus-
null infected cells, but it was significantly higher in the cells 
expressing wild-type or mutant Htt552.  Beclin1 is essential 
for the formation of autophagosomes and cytosol-to-vacuole 
vesicles
[29].  Beclin1 was also prominently increased after 
Htt552 expression.  In addition, the levels of cathepsin B and L 
were increased in Htt-expressing cells.  Both the expression of 
autophagy-related proteins and the enzymes found in lyso-
somes increased, suggesting that autophagy was activated in 
Htt-expressing cells (Figure 2).  
Both autophagy and proteasome prevent the accumulation of 
Htt552
The ubiquitin-proteasome system and autophagy/lysosome 
pathway are two primary protein degradation pathways 
that can be activated by different substrates.  Treatment with 
the autophagy inhibitor 3-MA or the proteasome inhibitors 
lactacystin and MG-132 increased Htt552 levels in PC12 cells 
infected with Ad-Htt-18Q-552 or Ad-Htt-100Q-552 (Figure 
3A).  The proteasome inhibitor caused a higher accumulation 
of Htt552-18Q than Htt552-100Q, and the autophagy inhibitor 
resulted in a higher accumulation of Htt552-100Q than Htt552-
18Q.  This suggests that the proteasome plays a key role in 
the metabolism of Htt552-18Q, whereas autophagy plays a 
major role in the metabolism of Htt552-100Q.  Similar results 
were observed for our primary cultured neurons infected with 
adenovirus (Figure 3B). These results support that both the 
ubiquitin-proteasome system and autophage-lysosomal path-
way play a role in the clearance of Htt552.  
Beclin1 redistributed from the nucleus in Htt552-expressing cells
The export of Beclin1 from the nucleus is the first step in the 
process of autophagy
[30].  Beclin1 deficiency leads to impaired 
autophagy function in mammalian cells
[26, 31].  Our immuno-
fluorescence results showed that the basal level of Beclin1 
was low and distributed mainly in the nucleus of control 
cells.  After expression of Htt552, the levels of Beclin1 greatly 
increased in the cytosol.  Furthermore, the expression of 
Beclin1 in the cytosol increased as the expression of Htt552 
increased (Figure 4).  
Htt siRNA prevented the redistribution of Beclin1 in starvation 
conditions
It is known that starvation or amino acid deprivation stimu-
lates the nuclear export of Beclin1 and activates autophagy.   
Thus, we evaluated the role of Htt in the redistribution of 
Beclin1 during starvation conditions.  The knockdown of 
endogenous Htt was achieved with the transfection of PC12 
cells with Htt siRNA.  The Htt siRNA was selected from 
three siRNAs that were designed based on Htt cDNA.  The 
endogenous Htt in PC12 cells was difficult to detect by normal 
Western blot; therefore, PC12 cells were transfected with Htt 
siRNAs 6 h before they were infected with Ad-Htt-18Q-552.   
Figure 1.  The expression of Htt552 in PC12 cells.  PC12 cells were 
infected with Ad-Htt-18Q-552, Ad-Htt-100Q-552, or Ad-null at MOI 30 and 
harvested 24 h later for Western blot analysis.  Both wild-type and mutant 
Htt552 were expressed at the expected molecular mass (A).  PC12 cells 
were infected with Ad-Htt-18Q-552, Ad-Htt-100Q-552 at MOI 30 for 24 h 
and then processed for double immunofluorescence of Htt (red) and 
the nuclear marker DAPI (blue).  Cells were examined with fluorescent 
microscopy (400×, scale bar=10 μm).  Both wild-type and mutant Htt552 
had a high expression of Htt552, and the rate of transfection reached 
approximately 60%–70%.  747
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After 24 h, Western blot analysis was used to detect the levels 
of Htt552.  siRNA3 was the most efficient in reducing Htt552 
expression and was used for the subsequent studies.  PC12 
cells were transfected with Htt siRNAs for 24 h in normal cul-
ture medium with 10% FBS and then in fresh medium without 
FBS for another 24 h.  The cells were harvested for immuno-
fluorescence procedure.  The results showed that the redis-
tribution of Beclin1 during starvation was inhibited by the 
knockdown of Htt552, suggesting that Htt may be involved in 
Beclin1 activation through the enhancement of Beclin1 export 
from the nucleus to the cytoplasm (Figure 5).  
Blockade of Beclin1 nuclear export or Beclin1 deficiency induced 
the formation of mHtt552 aggregates
The Rev-type NES forms a complex with the nuclear export 
receptor, CRM1, and Ran GTP.  Leptomycin B can bind to 
CRM1 and block the formation of this complex, thereby block-
ing the nuclear exportation of the Rev-type nuclear export sig-
nal (NES)-containing proteins.  Beclin1 contains a leptomycin 
B-sensitive leucine-rich nuclear export signal that is respon-
sible for its efficient nuclear export.  This export is required 
for autophagy and tumor suppressor function
[30].  Therefore, 
10 nmol/L leptomycin B was added to PC12 cells after Htt552 
expression.  Leptomycin B was added 18 h after adenovirus 
infection to prevent its influence on the viral infection capacity.   
After 24 h of treatment with leptomycin B, the cells were fixed 
and immunofluorescence was performed.  The results showed 
that leptomycin B restrained Beclin1 in the nucleus, and mHtt 
formed aggregates in the cytosol in some Htt-expressing cells 
(Figure 6B).  In addition, Western blot analysis showed that 
the expression of Htt552 increased after the treatment with 
leptomycin B (Figure 6A).  
To verify the important role of Beclin1 in Htt degradation, 
two Beclin1 siRNAs were designed and tested for their effi-
Figure 2.  Autophagy was activated by Htt552 
expression.  PC12 cells were infected with Ad-
Htt-18Q-552, Ad-Htt-100Q-552, or Ad-null at MOI 
30 and harvested 24 h later for Western blot 
analysis.  The protein levels of LC3 I and LC3 II 
increased after Htt552 expression.  The data are 
expressed as a ratio of LC3 II/LC3 I.  Beclin1, 
cathepsin B and the processed form of cathepsin L 
(bottom panel) were also upregulated after Htt552 
expression.  The densities of protein bands were 
analyzed with an image analyzer (Sigma Scan Pro 
5) and normalized to the loading control (β-actin).   
The data are represented as the mean±SEM.  
Statistical comparisons were carried out with an 




Wu JC et al
Acta Pharmacologica Sinica
npg
ciency in reducing Beclin1 levels.  siRNA1 was more efficient 
at reducing the levels of Beclin1 and was used in subsequent 
experiments.  The RNA interference of Beclin1 resulted in the 
formation of mutant Htt552 aggregates (Figure 7), suggesting 
that Beclin1 is involved in the clearance of Htt552.  
Discussion
The accumulation of misfolded proteins in the affected neu-
rons is a common characteristic of several neurological disor-
ders.  Macroautophagy (commonly referred to as autophagy) 
is a crucial cellular process for the bulk degradation of organ-
elles and long-lived proteins.  Cytoplasmic substrates are 
delivered via autophagosomes to lysosomes and degraded.   
Several studies have suggested an altered autophagy func-
tion in HD.  Our present results show that both proteasome 
and autophagy participate in the degradation of wild-type 
and mutant Htt552.  Previous data suggest that proteasome 
inhibition causes a greater accumulation of mutant Htt than 
inhibition of autophagy
[32].  According to our experiments, we 
believe that the different model systems and different concen-
trations of lactacystin or 3-MA can produce conflicting results.   
To verify the roles of these pathways, additional work should 
be done to determine the concentration and the specificity 
of stimulators or inhibitors of autophagy or the proteasome 
and utilize the knockdown of specific proteins.  However, our 
results are consistent with previous work which shows that 
both the proteasome and autophagy affect the degradation of 
Htt.  Far less is known about the molecular events controlling 
Htt degradation by autophagy in mammalian
 cells.  
Beclin1 is a mammalian ortholog of Atg6/Vps30, a compo-
nent of the Class III phosphatidylinositol 3-kinase complex in 
Figure 3.  Both the UPS and ALP play a role in the clearance of Htt552.  PC12 cells were infected with Ad-Htt-18Q-552, Ad-Htt-100Q-552, or Ad-null at 
MOI 30, and primary neurons were infected at MOI 100.  After 24 h, cells were treated with the proteasome inhibitors, MG132 and lactacystin, or the 
autophagy inhibitor, 3-MA, for 18 h.  Cells were then lysed for Western blot analysis.  Treatment with MG-132, lactacystin (left panel in A) and 3-MA (right 
panel in A) increased the levels of Htt552.  Treatment with 3-MA also increased the levels of Htt552 in rat primary cultured neurons (B).  The densities 
of protein bands were analyzed with an image analyzer (Sigma Scan Pro 5) and normalized to the loading control (β-actin).  The data are represented as 
the mean±SEM.  Statistical comparisons were carried out with an ANOVA followed by a Dunnett’s test.  
bP<0.05, 
cP<0.01 vs control.
Figure 4.  Beclin1 levels increased after Htt552 expression in PC12 
cells.  PC12 cells expressing Htt552 were fixed with pre-cooled EtOH and 
processed for double immunofluorescence of Htt552 (green) and Beclin1 
(red).  Cells were analyzed with a confocal microscope (600×).  After 
Htt552 expression, Beclin1 was upregulated in the cytoplasm but reduced 
in the nucleus, indicating the activation of Beclin1 and the presence 
of autophagy.  The thin arrow refers to Beclin1 in the nucleus, and the 
arrowhead refers to the export of Beclin1 to the cytoplasm.749
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[33].  The Class III PI 3-kinase and its product, PI 3-P, are 
involved in the autophagy signaling pathway.  It has been 
verified that Beclin1 contains a core of closely spaced leucine 
residues that conform to the consensus motif of the NES
[27, 30].   
Subcellular redistribution and compartmental sequestration 
of proteins have emerged as important mechanisms in the 
regulation of cellular responses.  Beclin1 plays an important 
role in macroautophagy by stimulating the formation of 
autophagosomes.  In our study, the levels of Beclin1 increased 
in the cytoplasm.  We also observed that the high expression 
of mHtt552 resulted in a greater effect on reducing the nuclear 
level of Beclin1 when compared to lower levels of mHtt552.   
Moreover, the downregulation of Beclin1 by siRNA and the 
inhibition of Beclin1 nuclear export by leptomycin B led to the 
accumulation of Htt552 and the formation of mHtt552 oligom-
ers, even aggregates.  These results indicate that Beclin1 is a 
Figure 5.  The effect of Htt on the activation of Beclin1.  PC12 cells were 
transfected with Htt siRNAs for 6 h.  They were then infected with Ad-Htt-
18Q-552 at MOI 30 and harvested 24 h later for Western blot analysis.   
siRNA3 was the most efficient of the samples tested (A).  Next, PC12 cells 
were transfected with Htt siRNA in normal culture medium with 10% FBS 
for 24 h and then changed to fresh medium without FBS and cultured 
for another 24 h.  Lastly, cells were harvested for immunofluorescence.   
Knockdown of Htt retained Beclin1 in the nucleus during starvation 
conditions (B).  This result suggests that the activation of Beclin1 was 
inhibited.
Figure 6.  Leptomycin B induced the formation of Htt552 aggregates.   
PC12 cells were infected with Ad-Htt-18Q-552, Ad-Htt-100Q-552, or Ad-
null at MOI 30 and were then treated with leptomycin B for 18 h.  Western 
blot results showed that leptomycin B inhibited the increase of Beclin1 
after Htt552 expression (A).  The densities of protein bands were analyzed 
with an image analyzer (Sigma Scan Pro 5) and normalized to the loading 
control (β-actin).  The data are represented as the mean±SEM.  Statistical 
comparisons were carried out using an ANOVA followed by Dunnett’s test.   
bP<0.05 vs cells without leptomycin B treatment.  Immunofluorescence 
results showed that leptomycin B restrained Beclin1 (red) in the nucleus 
(B).  Protein aggregates of mutant Htt552 (green) were observed in some 
cells.  Cells were detected with a confocal microscope (×600).750
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necessary protein in the autophagic degradation of Htt552.  
Our study suggests a possible role of Beclin1 in the 
autophagic degradation of mutant Htt552.  Thus, Beclin1 may 
be a useful target for the treatment of HD.  
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